Could cause temporary or reversible harm; serious harm is unlikely.
CGMP Deviations- Detection of N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit.
| Brand name | METFORMIN HYDROCHLORIDE |
| Generic name | METFORMIN HYDROCHLORIDE |
| Active ingredient(s) | METFORMIN HYDROCHLORIDE |
| Distributed by / for | VIONA PHARMACEUTICALS INC |
| NDC | 72578-036-01 |
| Full product label | Metformin Hydrochloride Extended-Release Tablets, USP 750 mg, 100 count HDPE bottles NDC# 72578-036-01 |
| Recalling firm | VIONA PHARMACEUTICALS INC |
| Distribution | Product was distributed to 17 wholesalers who further distributed the product to 85 locations. |
| Quantity | 23,8416/100 count bottles |
| Recall initiated | 2021-12-27 |
| Report date | 2022-02-02 |
| Recall completed | 2023-09-20 |
| Recall number | D-0392-2022 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Cranford NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗